GIP/GLP-1 Activity Confirmed
We tested the MediT tirzepatide using both GIP and GLP-1 receptor binding assays. Both showed expected activity levels consistent with properly folded tirzepatide. The prefilled pen maintained bioactivity across the full shelf life.









